Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGS Net product sales of FILSPARI totaled $50 million in 4Q 2024; $132 million for full yea ...

Qureight Ltd, a Core Imaging Laboratory developing deep-learning image analytics, and Vicore Pharma, a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 ...

Infertility is defined as the inability to be pregnant within one year of unprotected intercourse. It has become not only a ...

S L E is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a ...

Louisiana State Employees Retirement System boosted its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.4% during the 4th quarter, according to the company ...

为解决肾素合成、作用及肾素抑制保护肾功能机制不明等问题，UND Life Sciences 等机构研究人员开展肾素与花生四烯酸（AA）及其代谢产物关系研究。发现 AA 可调节肾素相关机制，为防治高血压、保护肾功能提供新思路，值得一读。